Analysis of the effect of biological therapy on SARS-CoV-2-specific antibody levels following booster vaccination in patients with inflammatory bowel disease

Project

Analysis of the effect of biological therapy on SARS-CoV-2-specific antibody levels following booster vaccination in patients with inflammatory bowel disease

Automatically Closed · 2022 until 2023

Brand Stephan, König Marius, Dütschler Joel, Krieger-Grübel Claudia, Eckhold Annika, Truniger Samuel, Frei Nicola Fabian, Albrich Werner

Type

Clinical Studies

Range

Multicentric, KSSG as main centre

Units

Gastroenterology/Hepatology, Allgemeine Innere Medizin | Hausarztmedizin und Notfallmedizin, Division of Infectious Diseases, Infection Prevention and Travel Medicine

Status

Automatically Closed

Start Date

2022

End Date

2023

Financing

Self Financed, KSSG

Partner

Inselspital Bern

Labels

esophagus cancer

Brief description/objective

This is a national multi-center cohort confirmatory study which is designed as a prospective
observational trial combined with retrospective data collection. Prospective data are collected
through a patient questionnaire and assessment of blood samples taken at inclusion.
Retrospective data are collected manually from patient medical records. The study design is
based on the CLARITY study.